Menu Close

UK CANCER CHARITY OPENS NEW HEADQUARTERS IN LEICESTER

National cancer charity, Mesothelioma UK has moved its operational team to offices at The Sidings in Leicester, and has held an official opening on today, Friday 15 December 2017.

Mesothelioma UK is a specialist resource centre, specifically for the asbestos-related cancer, mesothelioma. The charity was previously located at Glenfield Hospital, part of the University Hospitals of Leicester NHS Trust.

Photo Credit: Mesothelioma UK

Mesothelioma affects around 2,500 people per year in the UK, the highest incidence in the world. Mesothelioma UK provides specialist mesothelioma information, support and education, improving care and treatment for all UK mesothelioma patients and their carers. The charity also funds a team of 18 clinical nurse specialists across the UK.

The new headquarters were opened by HM Lord-Lieutenant of Leicestershire, Jennifer, Lady Gretton at a special ceremony on 15 December 2017, who said: “I am delighted to be asked to open the new headquarter building. I have followed the work of Mesothelioma UK for many years now and the services they provide are vital in improving the care available to sufferers of this awful disease.

“I am looking forward to being able to share in the excitement of moving to these dedicated premises and meeting the many people who have made it possible.”

Liz Darlison, Director of Mesothelioma UK, and Consultant Nurse at University Hospitals Leicester NHS Trust, said: “Our new offices will enable Mesothelioma UK to grow in order to provide improved support and information across the UK specifically for mesothelioma. The charity provides a freephone helpline for all, a benefits advisor service, fundraising and administration, funds research, national audit and a team of specialist nurses based in NHS hospital across the UK.

“These are exciting times in terms of mesothelioma treatment, care and the availability of clinical trials across the UK. We are pleased to focus on ensuring that every corner of the UK is informed about all treatment opportunities and are determined to ensure equitable access for all affected by the disease.”

 

RAF Advertisement